origin of glp 1 drugs Timeline GLP-1 discovery and clinical development. (a) Key events in How GLP-1 Receptor Agonists Evolved

They share a structural glutathione S -transferase (GST) fold with human chloride intracellular channels (HsCLICs)

[2] These impressive outcomes have generated interest in potential applications beyond the approved indications, though such use requires careful consideration of evidence and safety

In G6PD deficiency, the primary concern with these drugs is haemolytic anaemia rather than the rash, fever, or anaphylaxis associated with a true sulfa allergy

March 2015, Volume 54, Issue 2, pp 251263

They also used lab tests and genomic information to select nutritional supplements based on the twins DNA

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice